BRAIN Biotech AG (LON:0RFI)
2.290
-0.040 (-1.72%)
At close: Apr 8, 2025
BRAIN Biotech AG Revenue
BRAIN Biotech AG had revenue of 13.26M EUR in the quarter ending December 31, 2024, with 2.46% growth. This brings the company's revenue in the last twelve months to 55.82M, up 1.07% year-over-year. In the fiscal year ending September 30, 2024, BRAIN Biotech AG had annual revenue of 55.50M, down -1.29%.
Revenue (ttm)
55.82M EUR
Revenue Growth
+1.07%
P/S Ratio
0.95
Revenue / Employee
175.53K EUR
Employees
318
Market Cap
43.75M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 55.50M | -726.00K | -1.29% |
Sep 30, 2023 | 56.23M | 5.93M | 11.79% |
Sep 30, 2022 | 50.30M | 11.07M | 28.23% |
Sep 30, 2021 | 39.22M | 158.00K | 0.40% |
Sep 30, 2020 | 39.06M | -982.00K | -2.45% |
Sep 30, 2019 | Pro | Pro | Pro |
Sep 30, 2018 | Pro | Pro | Pro |
Sep 30, 2017 | Pro | Pro | Pro |
Sep 30, 2016 | Pro | Pro | Pro |
Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
Shell | 227.10B |
HSBC Holdings | 48.93B |
Unilever | 50.25B |
Rio Tinto Group | 42.86B |
RELX PLC | 9.43B |
British American Tobacco p.l.c. | 25.87B |
London Stock Exchange Group | 8.86B |